Optimal therapeutic management for cN1 M0 bladder cancer consists of perioperative systemic therapy and radical cystectomy. For patients with cN2-3 M0 disease, evidence supports upfront systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results